MedPath

Study on the Myocardial Protective Effect of Upper Limb Ischemic Preconditioning in Patients Undergoing Off-pump Coronary Artery Bypass Grafting

Not Applicable
Conditions
OPCABG
Interventions
Other: RIPC
Registration Number
NCT03340181
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

The purpose of the study was to verify the myocardial protective effect of RIPC in patients undergoing OPCABG.

Detailed Description

66 patients scheduled for OPCABG are randomly assigned to a RIPC group(n=33) or a control group(n=33). In the RIPC group, 4 cycles of 5-min ischemia(using a blood pressure cuff inflated to 40mmHg over the patient's basic blood pressure) and 5-min repercussion are done on an upper limb before skin incision. Patients in the control group wear the same cuff on an upper limb but no pressure is applied. Anesthetic and surgical techniques are standardized during the trial. Serum inflammatory cytokines and cardiac injury markers will be measured before and after surgery. Internal mammary artery and saphenous vein tissues will be collected during the surgery to assess hypoxia-inducible factor (Hif)-1a and other signalling proteins.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
66
Inclusion Criteria
  • serious changes in several coronary arteries that need to receive OPCABG
  • NHYA II-III
  • ASA II-III
Exclusion Criteria
  • LVEF< 35%
  • acute myocardial infarction
  • multiple organ dysfunction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controlRIPCpatient in control group using a blood pressure cuff on an upper limb without inflating
RIPCRIPC4 cycles of 5-min ischemia(using a blood pressure cuff inflated to 40mmHg over the patient's basic blood pressure) and 5-min repercussion are done on an upper limb.
Primary Outcome Measures
NameTimeMethod
ICU staying timeaverage of 1 year

the time patients spend in ICU after surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Huilin Wang

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath